| Bioactivity | VLHDDLLEA is a peptide that can be isolated from the MHC complex HLA-A*0201 molecule. VLHDDLLEA can be recognized by HLA-A*0201-restricted cytotoxic T cells (CTLs). VLHDDLLEA can be used for research on graft versus host disease (GvHD)[1]. |
| Name | VLHDDLLEA |
| CAS | 204931-32-8 |
| Sequence | Val-Leu-His-Asp-Asp-Leu-Leu-Glu-Ala |
| Shortening | VLHDDLLEA |
| Formula | C45H73N11O16 |
| Molar Mass | 1024.13 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. den Haan JM, et al. The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism. Science. 1998 Feb 13;279(5353):1054-7. d |
VLHDDLLEA
CAS: 204931-32-8 F: C45H73N11O16 W: 1024.13
VLHDDLLEA is a peptide that can be isolated from the MHC complex HLA-A*0201 molecule. VLHDDLLEA can be recognized by HLA
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.